Research Papers

25 of 432 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer.
Carm KT; Johannessen B; Bogaard M; Bakken AC; Maltau AV; Hoff AM; Axcrona U; Axcrona K; Lothe RA; Skotheim RI.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based …
Östman JR; Pinto RC; Ebbels TMD; Thysell E; Hallmans G; Moazzami AA.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A hybrid design for dose-finding oncology clinical trials.
Liao JJZ; Zhou F; Zhou H; Petruzzelli L; Hou K; Asatiani E.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen depriv…
Gedeborg R; Loeb S; Styrke J; Kiiski-Berggren R; Garmo H; Stattin P.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Agricultural activities and risk of central nervous system tumors among French farm managers: Results from the TRACTOR …
Petit P; Gandon G; Chabardès S; Bonneterre V.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
Xu B; Chen Y; Peng M; Zheng JH; Zuo C.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pregnancy duration and ovarian cancer risk: A 50-year nationwide cohort study.
Husby A; Wohlfahrt J; Melbye M.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Human papillomavirus self-sampling with mRNA testing benefits routine screening.
Auvinen E; Nieminen P; Pellinen J; Dillner J; Tarkkanen J; Virtanen A.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Improving identification of symptomatic cancer at primary care clinics: A predictive modeling analysis in Botswana.
Molebatsi K; Iyer HS; Kohler RE; Gabegwe K; Nkele I; Rabasha B; Botebele K; Barak T; Balosang S; Tapela NM; Dryden-Peterson SL.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Long-term survival of nonlocalized epithelial ovarian cancer among women using menopausal hormone therapy prior to diag…
Baandrup L; Galanakis M; Hannibal CG; Dehlendorff C; Hertzum-Larsen R; Mørch LS; Kjaer SK.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinica…
Todisco E; Gigli F; Ronchini C; Amato V; Sammassimo S; Pastano R; Parma G; Lapresa MT; Bertolini F; Corsini C; Gregato G; Poletti C; Pelicci PG; Alcalay M; Colombo N; Tarella C.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in …
Csizmarik A; Keresztes D; Nagy N; Bracht T; Sitek B; Witzke K; Puhr M; Tornyi I; Lázár J; Takács L; Kramer G; Sevcenco S; Maj-Hes A; Jurányi Z; Hadaschik B; Nyirády P; Szarvas T.
Int J Cancer (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
Wang S; Zheng R; Arnold M; Abnet C; Zeng H; Zhang S; Chen R; Sun K; Li L; An L; Bray F; Wei W; He J.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world …
Ratosa I; Dobnikar N; Bottosso M; Dieci MV; Jacot W; Pouderoux S; Ribnikar D; Sinoquet L; Guarneri V; Znidaric T; Darlix A; Griguolo G.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cance…
Faber MT; Frederiksen K; Palefsky JM; Kjaer SK.
Int J Cancer (Unknown)
Published: 2022
2/6 Transparent
Shared environment and colorectal cancer: A Nordic pedigree registry-based cohort study.
Elmahdi R; Wennerström ECM; Andersson M; Wohlfahrt J; Melbye M; Pukkala E; Hortlund M; Silander K; Sutinen K; Jess T; Dillner J.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications.
Wong KY; Cheung AH; Chen B; Chan WN; Yu J; Lo KW; Kang W; To KF.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
Vano YA; Phan L; Gravis G; Korakis I; Schlürmann F; Maillet D; Bennamoun M; Houede N; Topart D; Borchiellini D; Barthelemy P; Ratta R; Ryckewaert T; Hasbini A; Hans S; Emambux S; Cournier S; Braychenko E; Elaidi RT; Oudard S.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas.
von Knebel Doeberitz N; Paech D; Sturm D; Pusch S; Turcan S; Saunthararajah Y.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a bloc…
Nilsson T; Waraky A; Östlund A; Li S; Staffas A; Asp J; Fogelstrand L; Abrahamsson J; Palmqvist L.
Int J Cancer (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses …
Watts EL; Perez-Cornago A; Fensom GK; Smith-Byrne K; Noor U; Andrews CD; Gunter MJ; Holmes MV; Martin RM; Tsilidis KK; Albanes D; Barricarte A; Bueno-de-Mesquita B; Chen C; Cohn BA; Dimou NL; Ferrucci L; Flicker L; Freedman ND; Giles GG; Giovannucci EL; Goodman GE; Haiman CA; Hankey GJ; Huang J; Huang WY; Hurwitz LM; Kaaks R; Knekt P; Kubo T; Langseth H; Laughlin G; Le Marchand L; Luostarinen T; MacInnis RJ; Mäenpää HO; Männistö S; Metter EJ; Mikami K; Mucci LA; Olsen AW; Ozasa K; Palli D; Penney KL; Platz EA; Rissanen H; Sawada N; Schenk JM; Stattin P; Tamakoshi A; Thysell E; Tsai CJ; Tsugane S; Vatten L; Weiderpass E; Weinstein SJ; Wilkens LR; Yeap BB; PRACTICAL Consortium; CRUK; BPC3; CAPS; PEGASUS; Allen NE; Key TJ; Travis RC.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer.
Jain S; Nadeem N; Ulfenborg B; Mäkelä M; Ruma SA; Terävä J; Huhtinen K; Leivo J; Kristjansdottir B; Pettersson K; Sundfeldt K; Gidwani K.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting.
Burger EA; Laprise JF; Sy S; Regan MC; Prem K; Jit M; Brisson M; Kim JJ.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran.
Collatuzzo G; Etemadi A; Sotoudeh M; Nikmanesh A; Poustchi H; Khoshnia M; Pourshams A; Hashemian M; Roshandel G; Dawsey SM; Abnet CC; Kamangar F; Brennan P; Boffetta P; Malekzadeh R.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis …
Chen S; Gao Y; Wang Y; Daemen T.
Int J Cancer (Unknown)
Published: 2022
3/6 Transparent
Funding Declared